Enhetsprofil

Forskning

Our main aim is to improve outcome for the painful and fatal tumor disease, multiple myeloma (MM). To do this we pursue three lines of research; i) use investigator initiated clinical trials to test prevention strategies and ii) test new drug combinations in clinical trials and iii) investigate phagocyte subsets and functions during treatment and progression of MM.

Beskrivning

Ämnesklassifikation (UKÄ)

  • Hematologi

Nätverk

Externa samarbeten med länder/områden de senaste 5 åren